Although the literature on SRSF2 and stroke is limited, few studies suggested that some CH mutations may offer protection against brain injury.[51, 52] Investigating the specific pathomechanisms of individual CH mutations is crucial, as they may exert distinct effects on stroke outcomes.[5, 6, 7, 53, 54]. This evidence concerns the gene C4B and Stroke.